HM
Ningaloo Biosystems Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Optogenetic Bioproduction Platform | Manufacturing technology for complex biologics | Pre-clinical (Process Development) |
| Bispecific Antibody Production Application | Optimized manufacturing of bispecific antibodies | Pre-clinical (Proof-of-Concept) |